|

SC-CAR.GPC3xIL15.21 CAR T cells Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Seattle Children's Hospital1

Indications

  • Liver Disease1
  • Solid Tumor (Excluding CNS)1
  • Liver Cell Carcinoma1
  • Embryonal Sarcoma of Liver1
  • Hepatoblastoma1

Seattle, Washington1 trial

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

Seattle Children's Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.